The data are clear: Ebola vaccine shows ‘very impressive’ performance in outbreak
Of more than 90,000 people who were vaccinated against Ebola in DRC, only 71 went on to develop the disease.
The experimental Ebola vaccine being used to try to contain the outbreak in the Democratic Republic of the Congo is protective 97.5% of the time, according to new data released by the World Health Organization on Friday.
The data — the first to be released on how the vaccine is working in the outbreak — suggest a “very impressive” performance by the vaccine, said Michael Osterholm, director of the University of Minnesota’s Center for Infectious Diseases Research
